Results for koagulopatija translation from Maltese to English

koagulopatija
coagulopathy

tromboċitopenija*, koagulopatija*.
thrombocytopenia*, coagulopathy*.

avvenimenti assoċjati ma’ koagulopatija
events associated with coagulopathy

trombotika, panċitopenija, koagulopatija, emorraġija
purpura, pancytopenia, coagulopathy, haemorrhage

koagulopatija (disturbi fl-għaqid tad-demm)
coagulopathy (disturbance of blood clotting)

mhux komuni: newtropenija bid-deni, panċitopenija, koagulopatija.
uncommon: febrile neutropenia, pancytopenia, coagulopathy.

agranuloċitosi, koagulopatija, aplasja taċ-ċelluli l- ħomor, limfopenija
agranulocytosis, coagulopathy, red cell aplasia, lymphopenia

sindrome ħemolitika uremika, purpura trombotika tromboċitopenika, panċitopenja, koagulopatija, emorraġġija
haemolytic uraemic syndrome, thrombotic thrombocytopenic purpura, pancytopenia, coagulopathy, haemorrhage

dijateżi magħrufa tal-fsada, ħlief għal koagulopatija akuta relatata mas-sepsis
known bleeding diathesis except for acute coagulopathy related to sepsis

mard tal-fwied assoċjat ma’ koagulopatija u riskju ta’ fsada klinikament relevanti.
hepatic disease associated with coagulopathy and clinically relevant bleeding risk.

panċitopenija*, newtropenija bid-deni, koagulopatija*, lewkoċitosi*, limfodenopatija, anemija emolitika #
pancytopenia*, febrile neutropenia, coagulopathy*, leukocytosis*, lymphadenopathy, haemolytic anaemia#

kardjomijopatija emorraġika ġiet osservata fi ġrieden maskili biss u ġiet ikkunsidrata bħala sekondarja għal koagulopatija qawwija medjata via r- rotta tal- vitamina k.
haemorrhagic cardiomyopathy was only observed in male mice and was considered to be secondary to severe coagulopathy mediated via the vitamin k pathway.

kienu rrapportati xi ftit każijiet ta ’ disturbi koagulopatiċi bħal żieda fid- d - dimer u l- koagulopatija ta ’ konsum.
50 consumptive coagulopathy have been reported.

fil-każ li l-indeboliment epatiku jkun akkumpanjat minn koagulopatija, ara l-informazzjoni dwar l-effett fuq l-emostasi.
in case hepatic impairment is accompanied by coagulopathy see the information on the effect on haemostasis.

xarelto jista ’ jintuża b’ attenzjoni f’ pazjenti b’ ċirrożi b’ indeboliment epatiku moderat (child pugh b) jekk dan ma jkunx assoċjat ma ’ koagulopatija (ara sezzjonijiet 4. 2, 4. 3 u 5. 2).
xarelto may be used with caution in cirrhotic patients with moderate hepatic impairment (child pugh b) if it is not associated with coagulopathy (see sections 4.2, 4.3 and 5.2).